Clinical TrialID 7956
Tool for Fibromyalgia Diagnosis and Effect of Extra Virgin Olive Oil
NCT05921409
Fibromyalgia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7956
- Evidence Id
- 7956
- Core Evidence Id
- 7956
- Source Clinical Trial Id
- 7952
- Herb2 Clinical Trial Id
- HBCT007952
- Nct Id
- NCT05921409
- Title
- Tool for Fibromyalgia Diagnosis and Effect of Extra Virgin Olive Oil
- Status
- Active_Not_Recruiting
- Phase
- Study Result
- No
- Study Condition
- Fibromyalgia
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
- Intervention
- DIETARY_SUPPLEMENT: Extra Virgin Olive oil-supplemented Mediterranean Diet Intervention|DIETARY_SUPPLEMENT: Olive oil-supplemented Mediterranean Diet Intervention
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Diagnostic
- Gender
- Female
- Age
- Adult
- Enrollment
- 250
- Outcome Measure
- Concentration of Voltage dependent anion channel 1 protein (VDAC), VDAC protein determination by western blot, 0 weeks|Concentration of Voltage dependent anion channel 1 protein (VDAC), VDAC protein determination by western blot, 12 weeks|Concentration of Voltage dependent anion channel 1 protein (VDAC), VDAC protein determination by western blot, 24 weeks|Concentration of Voltage dependent anion channel 1 protein (VDAC), VDAC protein determination by western blot, 48 weeks|Concentration of Microtubule-associated proteins 1B light chain 3B (LC3B), LC3B protein determination by western blot, 0 weeks|Concentration of Microtubule-associated proteins 1B light chain 3B (LC3B), LC3B protein determination by western blot, 12 weeks|Microtubule-associated proteins 1B light chain 3B (LC3B), LC3B protein determination by western blot, 24 weeks|Concentration of Microtubule-associated proteins 1B light chain 3B (LC3B), LC3B protein determination by western blot, 48 weeks|Concentration of Plasma Proteins, Plasma proteome Analysis by label-free nano Liquid Chromatography coupled to tandem mass spectrometry after top-14 depletion, 0 weeks|Concentration of Plasma Proteins, Plasma proteome Analysis by label-free nano Liquid Chromatography coupled to tandem mass spectrometry after top-14 depletion, 12 weeks|Concentration of Plasma Proteins, Plasma proteome Analysis by label-free nano Liquid Chromatography coupled to tandem mass spectrometry after top-14 depletion, 24 weeks|Concentration of Plasma Proteins, Plasma proteome Analysis by label-free nano Liquid Chromatography coupled to tandem mass spectrometry after top-14 depletion, 48 weeks|Abundance of Bacteria from the Intestinal Microbiome, Fecal metagenomic analysis by amplicon sequencing of hypervariable region V3-V4 from RNA 16S bacterial gene, 0 weeks|Abundance of Bacteria from the Intestinal Microbiome, Fecal metagenomic analysis by amplicon sequencing of hypervariable region V3-V4 from RNA 16S bacterial gene, 12 weeks|Abundance of Bacteria from the Intestinal Microbiome, Fecal metagenomic analysis by amplicon sequencing of hypervariable region V3-V4 from RNA 16S bacterial gene, 24 weeks|Abundance of Bacteria from the Intestinal Microbiome, Fecal metagenomic analysis by amplicon sequencing of hypervariable region V3-V4 from RNA 16S bacterial gene, 48 weeks
- Sponsor Collaborator
- Pronacera Therapeutics SL|Centre for the Development of Industrial Technology, Spain
- Funded By
- INDUSTRY
- Location
- Pronacera Therapeutics Laboratory, Seville, 41015, Spain
- Other Id
- IDI20210749|IDI-20210749
- Start Date
- 2021-01-01
- Primary Completion Date
- 2023-08-31
- Completion Date
- 2023-12-31
- First Posted
- 2023-06-27
- Results First Posted
- Last Update Posted
- 2023-07-14
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05921409
- Title Cn
- Title En
- Tool for Fibromyalgia Diagnosis and Effect of Extra Virgin Olive Oil
- Bilingual Status
- semi_complete